CAS: 2068119-11-7
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | S18-000003 REF: 54-BUP09206CAS: 2068119-11-7 | ≥98% | 500,00 €~1.788,00 € | Lun 12 May 25 |
 | S18-000003 REF: TM-T16832CAS: 2068119-11-7 | 99.24% - 99.31% | 57,00 €~1.320,00 € | Vie 16 May 25 |
 | S18-000003 REF: 3D-THD11911CAS: 2068119-11-7 | Min. 95% | A consultar | Vie 20 Jun 25 |
Ref: 54-BUP09206
| 25mg | 500,00 € | ||
| 50mg | 702,00 € | ||
| 100mg | 971,00 € | ||
| 500mg | 1.788,00 € |
Entrega estimada en Estados Unidos, el Lunes 12 de Mayo de 2025
S18-000003
CAS:2068119-11-7
S18-000003: Oral retinoic acid receptor gamma-t inhibitor, IC50 29 nM, reduces IL-17 production.
Fórmula:
C26H25F3N2O4S
Pureza:
99.24% - 99.31%
Forma y color:
Solid
Peso molecular:
518.55
Ref: TM-T16832
| 1mg | 57,00 € | ||
| 5mg | 125,00 € | ||
| 10mg | 188,00 € | ||
| 25mg | 335,00 € | ||
| 50mg | 470,00 € | ||
| 100mg | 662,00 € | ||
| 500mg | 1.320,00 € | ||
| 1mL*10mM (DMSO) | 142,00 € |
Entrega estimada en Estados Unidos, el Viernes 16 de Mayo de 2025
S18-000003
CAS:2068119-11-7
Please enquire for more information about S18-000003 including the price, delivery time and more detailed …
Fórmula:
C26H25F3N2O4S
Pureza:
Min. 95%
Peso molecular:
518.5 g/mol
Ref: 3D-THD11911
| 5mg | 1.033,00 € | ||
| 10mg | 1.348,00 € | ||
| 25mg | 2.284,00 € | ||
| 50mg | 3.045,00 € | ||
| 100mg | 4.441,00 € |
Entrega estimada en Estados Unidos, el Viernes 20 de Junio de 2025
